Organic growth 3% Q3/Q2/FCF breakeven/Loss op's $(1.5mil )Organic growth calculation
Q2 revenue 24.24 mil
Mayhew .50 mil
Med supply .25 mil
Semo Drug .25 mil
Oxygen Plus .07 mil
Total 25.31 mil
Actual Q3 26.24 mil
Diff .93 mil
Or 3% Q/Q or 12% annualized.
CC will be key, as Q was as expected but miss on analyist EPS before FV adjustments/aquisition expenses and FCF targets. . .